Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Hepatocellular carcinoma is the most common primary liver cancer and the fourth leading cause of cancer death worldwide. A total of 70−80% of patients are diagnosed at an advanced stage with a dismal prognosis. Sorafenib had been the standard care for almost a decade until 2018 when the Food a...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2019-10-01
|
| Serija: | Medicina |
| Teme: | |
| Online pristup: | https://www.mdpi.com/1010-660X/55/10/698 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|